# A&g Pharmaceutical, Inc.

Canonical: https://abierto.us/vendors/a-and-g-pharmaceutical-inc-sn6swfabjxl1

- UEI: SN6SWFABJXL1
- CAGE: 1T9L5
- Location: Columbia, MD
- Awards in window: 4 (5 transactions), -$27,704 obligated, January 30, 2026 to August 26, 2026

## Awarding agencies

- National Institutes of Health: 4 awards, -$27,704

## Industries

- 325412 Pharmaceutical Preparation Manufacturing: $0
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology): -$1,479
- 541380 Testing Laboratories and Services: -$26,225

## Competition

- Not Competed Under SAP: 2 awards
- Full and Open Competition: 1 awards

## Largest awards

- 75N98024A00057: $0, National Institutes of Health Olao. O/M Items Only: Biological Materials, Laboratory & Testing Services, Animal Testing Services. https://www.usaspending.gov/award/CONT_IDV_75N98024A00057_7529/
- 75N95022F00001 (delivery order): -$1,479, National Institutes of Health Nida. FY26 Udo Initiative Polyclonal Rat Antibody and Monoclonal Rat Antibodies Against Glycol-Chitosan Nanoparticles. https://www.usaspending.gov/award/CONT_AWD_75N95022F00001_7529_75N95018D00010_7529/
- 75N93024P01059 (purchase order): -$3,000, National Institutes of Health Niaid. FY26 Udo Initiative Precision Antibody (Ambis #2229539) Lab Testing, Fusion, Cloning. https://www.usaspending.gov/award/CONT_AWD_75N93024P01059_7529_-NONE-_-NONE-/
- 75N93021P01162 (purchase order): -$23,225, National Institutes of Health Niaid. To Administratively De-Obligate Unexpended and Expiring Fiscal Year 2021 Funding in Accordance with 31 U.S.C. Section 1552 (A), in Preparation for September 30, 2026, Closing of the Period of Availability of These Fiscal Year Funds.. https://www.usaspending.gov/award/CONT_AWD_75N93021P01162_7529_-NONE-_-NONE-/

---
Source: USAspending.gov award data, keyed by UEI. Obligations in the window only. Cite https://abierto.us/vendors/a-and-g-pharmaceutical-inc-sn6swfabjxl1.